Davis Hugh M. 4

4 · Aclaris Therapeutics, Inc. · Filed Feb 6, 2026

AI-generated summary of this filing

Updated Feb 6, 2026

Aclaris (ACRS) President/COO Hugh M. Davis Receives RSU Award

What Happened

Hugh M. Davis, President and COO (and Director) of Aclaris Therapeutics, received two grants of restricted stock units (RSUs) on Feb 2, 2026: 96,100 RSUs and 336,300 RSUs, for a total of 432,400 RSUs. The awards were granted at $0.00 (no cash paid) and are reported as derivative securities (contingent rights to common stock).

Key Details

Transaction date: 2026-02-02; Form 4 filed: 2026-02-06 (Period of Report: 2026-02-02). No late-filing flag provided in the supplied data.
Award amounts/prices: 96,100 RSUs @ $0.00 and 336,300 RSUs @ $0.00 (total 432,400 RSUs).
What the derivatives mean: Each RSU is a contingent right to receive one share of common stock upon vesting (Footnote F1).
Vesting: The RSUs vest in four equal annual installments on the 1st, 2nd, 3rd and 4th anniversaries of Feb 2, 2026, subject to continuous service (Footnote F2).
Additional note: Footnote F3 describes a 25%/4-year style vesting schedule applicable to option awards (included in the filing).
Shares owned after transaction: Not specified in the information provided here — see the full Form 4 for post-transaction holdings.

Context

These were compensation awards (RSUs), not open-market purchases or sales. Awards do not require an immediate cash outlay and do not represent an immediate bullish or bearish trade by the insider; they are typical executive compensation that can dilute outstanding shares if/when settled.
Vesting is service-based; shares will only be issued if vesting conditions (continuous service) are met on each anniversary.

Form 4

Period: 2026-02-02

DirectorPresident and COO

Transactions

Award
Restricted Stock Units
[F1][F2]
2026-02-02+96,100→ 96,100 total
→ Common Stock (96,100 underlying)
Award
Employee Stock Option (Right to Buy)
[F3]
2026-02-02+336,300→ 336,300 total
Exercise: $3.61Exp: 2036-02-01→ Common Stock (336,300 underlying)

Footnotes (3)

[F1]Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
[F2]The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of February 2, 2026, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.
[F3]Exercisable with respect to 25% of the shares subject to the option vesting in four equal installments on the first, second, third and fourth anniversaries of February 2, 2026, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.

Signature

/s/ Matthew Rothman, Attorney-in-Fact|2026-02-06

1 file